Back to Search
Start Over
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study
- Source :
- The Journal of Allergy and Clinical Immunology: In Practice; 20230101, Issue: Preprints
- Publication Year :
- 2023
-
Abstract
- Uncontrolled asthma in growing children can impair lung growth that may lead to adverse complications in later life. Dupilumab, a human monoclonal antibody, blocks the shared receptor for IL-4 and IL-13, key drivers of type 2 inflammation.
Details
- Language :
- English
- ISSN :
- 22132198
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- The Journal of Allergy and Clinical Immunology: In Practice
- Publication Type :
- Periodical
- Accession number :
- ejs64849199
- Full Text :
- https://doi.org/10.1016/j.jaip.2023.12.006